I G Schmidt-Wolf

1.4k total citations · 1 hit paper
24 papers, 1.0k citations indexed

About

I G Schmidt-Wolf is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, I G Schmidt-Wolf has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in I G Schmidt-Wolf's work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers) and Virus-based gene therapy research (4 papers). I G Schmidt-Wolf is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers) and Virus-based gene therapy research (4 papers). I G Schmidt-Wolf collaborates with scholars based in Germany, United States and Switzerland. I G Schmidt-Wolf's co-authors include KG Blume, Hans‐Peter Kiem, RS Negrin, I L Weissman, Angela Märten, Elisabeth Sievers, Axel Glasmacher, Uwe Schlegel, T. Sauerbruch and Michael Linnebank and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

I G Schmidt-Wolf

23 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

1991 518 citations I G Schmidt-Wolf, RS Negrin et al. The Journal of Experimental Medicine profile →

Peers

I G Schmidt-Wolf

ONCOL

IMMUN

HEMAT

GENET

Anna Morabito Italy

Sijie Lu United States

Lequn Li United States

Chiara Casati Italy

Antonia Busse Germany

Tae Kon Kim United States

Jennifer Baker United Kingdom

Cathy Quilici Australia

Consuelo Anzilotti United Kingdom

Elisabetta Dondi France

Anna Morabito Italy

I G Schmidt-Wolf

447 ×0.7

ONCOL

559 ×0.9

IMMUN

223 ×1.2

77 ×0.8

HEMAT

83 ×1.0

GENET

Citations per year, relative to I G Schmidt-Wolf I G Schmidt-Wolf (= 1×) peers Anna Morabito

Countries citing papers authored by I G Schmidt-Wolf

Since Specialization

Citations

This map shows the geographic impact of I G Schmidt-Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I G Schmidt-Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I G Schmidt-Wolf more than expected).

Fields of papers citing papers by I G Schmidt-Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I G Schmidt-Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I G Schmidt-Wolf. The network helps show where I G Schmidt-Wolf may publish in the future.

Co-authorship network of co-authors of I G Schmidt-Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of I G Schmidt-Wolf. A scholar is included among the top collaborators of I G Schmidt-Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I G Schmidt-Wolf. I G Schmidt-Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grünwald, Viktor, S. Weikert, I G Schmidt-Wolf, et al.. (2014). Aset Study: Final Results of Patients with Locally Recurrent or Metastatic Renal Cell Carcinoma (Rcc) Treated with Mgn1601. Annals of Oncology. 25. iv366–iv366. 2 indexed citations

Linnebank, Michael, Annika Kowoll, Christopher Bangard, et al.. (2012). Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma. British Journal of Cancer. 107(11). 1840–1843. 2 indexed citations

Caspari, Reiner, Matthias Jungck, C. Lamberti, et al.. (2008). Diagnostik hereditärer kolorektaler Karzinome^*. DMW - Deutsche Medizinische Wochenschrift. 125(6). 153–158.

Schmidt, Matthias, Elisabeth Sievers, Tomoyuki Endo, et al.. (2008). Targeting Wnt pathway in lymphoma and myeloma cells. British Journal of Haematology. 144(5). 796–798. 23 indexed citations

Märten, Angela, Per Hoffmann, Elisabeth Sievers, et al.. (2006). Patient‐derived dendritic cells transduced with an a‐fetoprotein‐encoding adenovirus and co‐cultured with autologous cytokine‐induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. Liver International. 26(3). 369–379. 43 indexed citations

Bogdanow, M., et al.. (2006). Adjuvante und palliative Chemotherapie des kolorektalen Karzinoms in Deutschland außerhalb kontrollierter Studien. DMW - Deutsche Medizinische Wochenschrift. 131(10). 485–490. 3 indexed citations

Lamberti, C., Elisabeth Mangold, Constanze Pagenstecher, et al.. (2006). Frequency of Hereditary Non-Polyposis Colorectal Cancer among Unselected Patients with Colorectal Cancer in Germany. Digestion. 74(1). 58–67. 23 indexed citations

Fimmers, Rolf, Micaela Mathiak, Magdolna Bollmann, et al.. (2005). Population-Based Registration of Unselected Colorectal Cancer Patients: Five-Year Survival in the Region of Bonn/Rhine-Sieg, Germany. Zeitschrift für Gastroenterologie. 43(2). 149–154. 8 indexed citations

Schmidt, Jan, Eduard Ryschich, Elisabeth Sievers, et al.. (2005). Telomerase‐specific T‐cells kill pancreatic tumor cells in vitro and in vivo. Cancer. 106(4). 759–764. 15 indexed citations

10.

Riess, Hanno, A. Helm, Marco Niedergethmann, et al.. (2005). A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer. Journal of Clinical Oncology. 23(16_suppl). LBA4009–LBA4009. 80 indexed citations

11.

Linnebank, Michael, Stephan Schmidt, Heike Kölsch, et al.. (2004). The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. British Journal of Cancer. 90(10). 1969–1971. 33 indexed citations

12.

Mey, Ulrich, et al.. (2003). Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial. Anti-Cancer Drugs. 14(3). 233–238. 15 indexed citations

13.

Lefterova, Petja, et al.. (2000). MODULATION OF CELL SURFACE MARKERS ON NK-LIKE T LYMPHOCYTES BY USING IL-2, IL-7 OR IL-12 IN VITRO STIMULATION. Cytokine. 12(9). 1385–1390. 29 indexed citations

14.

Trojaneck, Beate, Petja Lefterova, D. Huhn, et al.. (2000). COMPARISON OF NON-VIRAL TRANSFECTION METHODS IN MELANOMA CELL PRIMARY CULTURES. Cytokine. 12(6). 828–833. 6 indexed citations

15.

Flieger, Dimitri, Ulrich Spengler, Imke Beier, Tilman Sauerbruch, & I G Schmidt-Wolf. (2000). Prestimulation of monocytes by the cytokines GM-CSF or IL- 2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A1. Zeitschrift für Gastroenterologie. 38(8). 615–622. 7 indexed citations

16.

Mann, B., Alexei Gratchev, Christian Böhm, et al.. (1999). FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas. British Journal of Cancer. 79(7-8). 1262–1269. 67 indexed citations

17.

Schriever, Folke, et al.. (1997). Human T lymphocytes bind to germinal centers of human tonsils via integrin α4/VCAM‐1 and LFA‐1/ICAM−1 and −2. European Journal of Immunology. 27(1). 35–39. 20 indexed citations

18.

Schmidt‐Wolf, Gabriele & I G Schmidt-Wolf. (1996). Cancer and gene therapy. Annals of Hematology. 73(5). 207–218. 12 indexed citations

19.

Schmidt‐Wolf, Gabriele & I G Schmidt-Wolf. (1995). Bone Marrow and Clinical Gene Therapy. Journal of Hematotherapy. 4(6). 551–561. 1 indexed citations

20.

Schmidt-Wolf, I G, RS Negrin, Hans‐Peter Kiem, KG Blume, & I L Weissman. (1991). Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.. The Journal of Experimental Medicine. 174(1). 139–149. 518 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact